Impact of treatment duration of neoadjuvant FIRINOX in patients with borderline resectable pancreatic cancer: a pilot trial
Crossref DOI link: https://doi.org/10.1007/s00280-016-3121-8
Published Online: 2016-08-08
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okada, Ken-ichi
Kawai, Manabu
Hirono, Seiko
Satoi, Sohei
Yanagimoto, Hiroaki
Ioka, Tatsuya
Miyazawa, Motoki
Shimizu, Atsushi
Kitahata, Yuji
Yamaue, Hiroki
License valid from 2016-08-08